| Jessica Engle, DO | |
|
600 N Wolfe St, Baltimore, MD 21287-0005 | |
| (410) 614-4030 | |
| Not Available |
| Full Name | Jessica Engle |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 13 Years |
| Location | 600 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194017731 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | H0082054 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Largo, MD | Home health agency |
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
Pharmaceutical manufacturers and national authorities often negotiate secret rebates when determining drug prices. A UZH study shows that these rebate systems may hamper patient access to drugs. In the medium term, this practice can even lead to increasing drug prices.
Scientists have discovered for the first time how humans - and other mammals - have evolved to have intelligence.
› Verified 9 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
Pharmaceutical manufacturers and national authorities often negotiate secret rebates when determining drug prices. A UZH study shows that these rebate systems may hamper patient access to drugs. In the medium term, this practice can even lead to increasing drug prices.
Scientists have discovered for the first time how humans - and other mammals - have evolved to have intelligence.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Engle, DO 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: (410) 933-1340 | Jessica Engle, DO 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 614-4030 |
News Archive
Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
Pharmaceutical manufacturers and national authorities often negotiate secret rebates when determining drug prices. A UZH study shows that these rebate systems may hamper patient access to drugs. In the medium term, this practice can even lead to increasing drug prices.
Scientists have discovered for the first time how humans - and other mammals - have evolved to have intelligence.
› Verified 9 days ago
Robert S Mayer, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-532-4701 | |
Nia C Wallace Ward, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 707 N Broadway, Kennedy Krieger Institute, Baltimore, MD 21205 Phone: 443-923-9200 Fax: 443-923-9405 | |
Susan Miller, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7500 Security Blvd, Mailstop: C1-09-06, Baltimore, MD 21244 Phone: 410-786-2118 | |
Christine Yunjae Wang, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-9000 | |
Jason P Brokaw, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2700 Quarry Lake Drive, Suite 300, Baltimore, MD 21209 Phone: 410-377-8900 Fax: 410-377-3156 | |
Pablo Ariel Celnik, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-532-4701 | |
Behnam Jafarpour, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3421 Benson Ave, Suite 210, Baltimore, MD 21227 Phone: 443-693-7246 |